Irutė Girkontaitė

Dr. Irutė Girkontaitė

Department of Immunology, State Research Institute Centre for Innovative Medicine, 08410 Vilnius, Lithuania
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
AKAglaja Kopf
Aglaja Kopf
JRJörg Renkawitz
Jörg Renkawitz
RHRobert Hauschild
Robert Hauschild
IGIrutė Girkontaitė
Irutė Girkontaitė
KTKerry Tedford
Kerry Tedford
MSMichael Sixt
Michael Sixt
Cells navigating through complex tissues face a fundamental challenge: while multiple protrusions explore different paths, the cell needs to avoid entanglement. How a cell surveys and then corrects its own shape is poorly understood. Here, we demonstrate that spatially distinct microtubule dynamics regulate amoeboid cell migration by locally promoting the retraction of protrusions. In migrating dendritic cells, local microtubule depolymerization within protrusions remote from the microtubule organizing center triggers actomyosin contractility controlled by RhoA and its exchange factor Lfc. Depletion of Lfc leads to aberrant myosin localization, thereby causing two effects that rate-limit locomotion: (1) impaired cell edge coordination during path finding and (2) defective adhesion resolution. Compromised shape control is particularly hindering in geometrically complex microenvironments, where it leads to entanglement and ultimately fragmentation of the cell body. We thus demonstrate that microtubules can act as a proprioceptive device: they sense cell shape and control actomyosin retraction to sustain cellular coherence.

6 December 2017 in Science Translational Medicine
Verified
Journal Article
Open access
PDF file
RCRyan F. Coghlan
Ryan F. Coghlan
JOJon A. Oberdorf
Jon A. Oberdorf
SSSusan Sienko
Susan Sienko
MAMichael D. Aiona
Michael D. Aiona
BBBruce A. Boston
Bruce A. Boston
WHWilliam A. Horton
William A. Horton
A type X collagen fragment derived from endochondral ossification and detected in blood is a marker for growth velocity.

9 November 2019 in Cancers
Verified
Journal Article
Open access
PDF file
Vitalij NovickijVitalij Novickij
Vitalij Novickij
RČRobertas Čėsna
Robertas Čėsna
EPEmilija Perminaitė
Emilija Perminaitė
AZAuksė Zinkevičienė
Auksė Zinkevičienė
DCDainius Characiejus
Dainius Characiejus
IGIrutė Girkontaitė
Irutė Girkontaitė
In this work, we have investigated the feasibility of sub-microsecond range irreversible electroporation (IRE) with and without calcium electroporation in vivo. As a model, BALB/C mice were used and bioluminescent SP2/0 myeloma tumor models were developed. Tumors were treated with two separate pulsed electric field (PEF) pulsing protocols PEF1: 12 kV/cm × 200 ns × 500 (0.006 J/pulse) and PEF2: 12 kV/cm × 500 ns × 500 (0.015 J/pulse), which were delivered with and without Ca2+ (168 mM) using parallel plate electrodes at a repetition frequency of 100 Hz. Both PEF1 and PEF2 treatments reduced tumor growth and prolonged the life span of the mice, however, the PEF2 protocol was more efficient. The delay in tumor renewal was the biggest when a combination of IRE with calcium electroporation was used, however, we did not obtain significant differences in the final mouse survival compared to PEF2 alone. Anti-tumor immune responses were also investigated after treatment with PEF2 and PEF2+Ca. In both cases the treated mice had enlarged spleens and increased spleen T cell numbers, lower percentages of suppressor cell subsets (conventional CD4+CD25+ Treg, CD4+CD25−DX5+ Tr1, CD8+DX5+, CD4+CD28−, CD8+CD28−), changed proportions of Tcm and Tef/Tem T cells in the spleen and increased amount of tumor cell specific antibodies in the sera. The treatment based on IRE was effective against primary tumors, destroyed the tumor microenvironment and induced an anti-tumor immune response, however, it was not sufficient for complete control of tumor metastasis.

9 October 2020 in Molecules
Verified
Journal Article
Open access
PDF file
Vitalij NovickijVitalij Novickij
Vitalij Novickij
VMVeronika Malyško
Veronika Malyško
AŽAugustinas Želvys
Augustinas Želvys
ABAusteja Baleviciute
Austeja Baleviciute
AZAuksė Zinkevičienė
Auksė Zinkevičienė
IGIrutė Girkontaitė
Irutė Girkontaitė
Pulsed electric field (PEF) is frequently used for intertumoral drug delivery resulting in a well-known anticancer treatment—electrochemotherapy. However, electrochemotherapy is associated with microsecond range of electrical pulses, while nanosecond range electrochemotherapy is almost non-existent. In this work, we analyzed the feasibility of nanosecond range pulse bursts for successful doxorubicin-based electrochemotherapy in vivo. The conventional microsecond (1.4 kV/cm × 100 µs × 8) procedure was compared to the nanosecond (3.5 kV/cm × 800 ns × 250) non-thermal PEF-based treatment. As a model, Sp2/0 tumors were developed. Additionally, basic current and voltage measurements were performed to detect the characteristic conductivity-dependent patterns and to serve as an indicator of successful tumor permeabilization both in the nano and microsecond pulse range. It was shown that nano-electrochemotherapy can be the logical evolution of the currently established European Standard Operating Procedures for Electrochemotherapy (ESOPE) protocols, offering better energy control and equivalent treatment efficacy.

3 April 2019 in BMC Microbiology
Verified
Journal Article
Open access
PDF file
Vitalij NovickijVitalij Novickij
Vitalij Novickij
Eglė LastauskienėEglė Lastauskienė
Eglė Lastauskienė
GSGediminas Staigvila
Gediminas Staigvila
IGIrutė Girkontaitė
Irutė Girkontaitė
AZAuksė Zinkevičienė
Auksė Zinkevičienė
JNJurij Novickij
Jurij Novickij
Skin infections, particularly caused by drug-resistant pathogens, represent a clinical challenge due to being a frequent cause of morbidity and mortality. The objectives of this study were to examine if low concentrations of acetic and formic acids can increase sensitivity of Staphylococcus aureus and Pseudomonas aeruginosa to pulsed electric field (PEF) and thus, promote a fast and efficient treatment methodology for wound treatment. We have shown that the combination of PEF (10–30 kV/cm) with organic acids (0.1% formic and acetic acids) increased the bactericidal properties of treatment. The effect was apparent for both acids. The proposed methodology allowed to reduce the energy of electrical pulses and the inhibitory concentrations of acids, while still maintain high efficiency of bacteria eradication. Application of weak organic acids as bactericidal agents has many advantages over antibiotics because they do not trigger development of drug-resistance in bacteria. The combination with PEF can make the treatment effective even against biofilms. The results of this study are particularly useful for the development of new methodologies for the treatment of extreme cases of wound infections when the chemical treatment is no longer effective or hinders wound healing.

11 June 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
EREivina Radzevičiūtė
Eivina Radzevičiūtė
Veronika MalyškoVeronika Malyško
Veronika Malyško
Jurij NovickijJurij Novickij
Jurij Novickij
Vitalij NovickijVitalij Novickij
Vitalij Novickij
IGIrutė Girkontaitė
Irutė Girkontaitė
Gene transfer into primary immune cells as well as into cell lines is essential for scientific and therapeutical applications. One of the methods used for gene transfer is electroporation (EP). EP is a method where a pulsed electric field (PEF) causes a highly transient permeability of the targeted cell membrane. In this work, we present the electrotransfection of CHO-K1, 4T1 cell lines, and primary murine DCs with detectable protein-encoding plasmids in the sub-microsecond range. Microsecond (µs)- and nanosecond (ns)-range pulsed electric field transfection protocols were used. The efficiency of electrotransfection was evaluated using green fluorescent protein (GFP)-encoding plasmids (4.7 kbp; p-EGFP-N1) and plasmids expressing a firefly luciferase and red fluorescent protein (tdTomato) (8.5 kbp; pcDNA3.1(+)/Luc2 = tdT)). It was shown that the used nsPEFs protocol (7 kV/cm × 300 ns × 100, 1 MHz) ensured a better transfection efficiency than µsPEFs (1.2 kV/cm × 100 µs × 8, 1 Hz). Plasmid size and concentration had a strong impact on the cell transfection efficiency too. We also showed that there were no significant differences in transfection efficiency between immature and mature DCs. Finally, the nsPEF protocols were successfully applied for the stable transfection of the CHO-K1 cell line with the linearized pcDNA3.1(+)/Luc2 = tdT plasmid. The results of the study are applicable in gene therapy and DNA vaccination studies for the derivation of optimal electrotransfection conditions.